Sign In
Buy WFC
$78.70
-0.745 (-0.94%)
At Close: Jun 03, 2026
Is Trending Stock Wells Fargo & Company (WFC) a Buy Now?
10:00am, Tuesday, 16'th Sep 2025
Wells Fargo (WFC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Wells Fargo (WFC) Could Be a Great Choice
12:46pm, Friday, 12'th Sep 2025
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Wells Fargo (WFC) have what it takes?
Wells Fargo Highlights Future Growth Path at Barclays Conference
01:10pm, Thursday, 11'th Sep 2025
WFC outlines its post asset cap growth strategy, targeting efficiency gains, stable NII, and expansion in lending and wealth management.
Financial CEOs are weighing in on the state of the economy
09:44am, Thursday, 11'th Sep 2025
Amid economic uncertainty and a Bureau of Labor Statistics preliminary report revising down job numbers, CEOs weighed in this week on CNBC. Ranging from JPMorgan Chase CEO Jamie Dimon to PNC Financial
Wells Fargo CEO: Trump is entitled to be vocal about the Fed
03:14pm, Wednesday, 10'th Sep 2025
Wells Fargo CEO Charlie Scharf said he "absolutely" supports the Federal Reserve's independence, but that President Donald Trump is free to express his beliefs on how the central bank should set monet
Wells Fargo CEO says Trump is entitled to be vocal about the Fed
12:00pm, Wednesday, 10'th Sep 2025
Wells Fargo CEO Charlie Scharf said he supports the Federal Reserve's independence and believes the central bank is still independent. Scharf added that he believes President Donald Trump is entitled
Wells Fargo CEO sees 'more downside' to U.S. economy as lower-income consumers struggle
11:39am, Wednesday, 10'th Sep 2025
Wells Fargo CEO Charles Scharf said Wednesday that while corporations and higher-income consumers are thriving, lower income Americans are struggling to stay afloat.
Wells Fargo CEO sees 'more downside' to U.S. economy as lower-income consumers struggle
09:26am, Wednesday, 10'th Sep 2025
Wells Fargo CEO Charles Scharf said Wednesday that while corporations and higher-income consumers are thriving, lower income Americans are struggling to stay afloat. The bank's data shows that while "
Wells Fargo CEO Charles Scharf: There's a big dichotomy between higher- and lower-income consumers
09:05am, Wednesday, 10'th Sep 2025
Wells Fargo CEO Charles Scharf joins 'Squawk Box' to discuss the state of the economy, state of the consumer, consumer spending, impact of AI, state of banking, Fed independence, latest market trends,
Wells Fargo (WFC) Exceeds Market Returns: Some Facts to Consider
06:46pm, Tuesday, 09'th Sep 2025
In the latest trading session, Wells Fargo (WFC) closed at $80.76, marking a +2.05% move from the previous day.
JPM, C & Others Face Pressure to Lend More Than Reward Shareholders
02:31pm, Tuesday, 09'th Sep 2025
Senators Warren and Sanders urge JPMorgan, Citigroup, WFC, MS and peers to prioritize lending over shareholder payouts.
Aequum Capital Secures $250 Million Debt Facility with Wells Fargo to Accelerate Growth
12:04pm, Tuesday, 09'th Sep 2025
CHICAGO , Sept. 9, 2025 /PRNewswire/ -- Aequum Capital Financial, LLC ("Aequum"), a rapidly growing specialty finance lender backed by Castlelake, L.P.
Wells Fargo & Company (WFC) Presents At Barclays 23rd Annual Global Financial Services Conference Transcript
11:26am, Tuesday, 09'th Sep 2025
Wells Fargo & Company (NYSE:WFC ) Barclays 23rd Annual Global Financial Services Conference September 9, 2025 8:15 AM EDT Company Participants Michael Santomassimo - Senior EVP & CFO Presentation Unkn
Gordon Brothers Propels Commercial Equipment Finance with $1.5B Joint Venture
09:00am, Thursday, 04'th Sep 2025
Increased capital base expands the firm's ability to provide tailored financing solutions to middle-market and large corporate companies across key sectors Increased capital base expands the firm's ab
Wave Life Sciences price target lowered to $18 from $21 at Wells Fargo
06:36am, Thursday, 04'th Sep 2025
Wells Fargo analyst Tiago Fauth lowered the firm's price target on Wave Life Sciences to $18 from $21 and keeps an Overweight rating on the shares after the company reported AATD data update for 200 a
